Articles with public access mandates - Dukagjin M. BlakajLearn more
Not available anywhere: 3
68Ga-DOTATATE PET-based radiation contouring creates more precise radiation volumes for patients with meningioma
HK Perlow, M Siedow, Y Gokun, J McElroy, J Matsui, W Zoller, S Beyer, ...
International Journal of Radiation Oncology* Biology* Physics 113 (4), 859-865, 2022
Mandates: US National Institutes of Health
Platinum‐based regimens versus cetuximab in definitive chemoradiation for human papillomavirus‐unrelated head and neck cancer
TH Beckham, C Barney, E Healy, AR Wolfe, A Branstetter, A Yaney, ...
International journal of cancer 147 (1), 107-115, 2020
Mandates: US National Institutes of Health
Dose-Volume Tolerance of the Brain and Predictors of Radiation Necrosis After 3-Fraction Radiosurgery for Brain Metastases: A Large Single-Institutional Analysis
R Upadhyay, AS Ayan, S Jain, BG Klamer, HK Perlow, W Zoller, ...
International Journal of Radiation Oncology* Biology* Physics 118 (1), 275-284, 2024
Mandates: US National Institutes of Health
Available somewhere: 28
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
ML Gillison, AM Trotti, J Harris, A Eisbruch, PM Harari, DJ Adelstein, ...
The Lancet 393 (10166), 40-50, 2019
Mandates: US National Institutes of Health, Damon Runyon Cancer Research Foundation
Reduced-dose radiation therapy for HPV-associated oropharyngeal carcinoma (NRG Oncology HN002)
SS Yom, P Torres-Saavedra, JJ Caudell, JN Waldron, ML Gillison, P Xia, ...
Journal of Clinical Oncology 39 (9), 956-965, 2021
Mandates: US National Institutes of Health
Phase IIb, randomized, double-blind trial of GC4419 versus placebo to reduce severe oral mucositis due to concurrent radiotherapy and cisplatin for head and neck cancer
CM Anderson, CM Lee, DP Saunders, A Curtis, N Dunlap, C Nangia, ...
Journal of Clinical Oncology 37 (34), 3256-3265, 2019
Mandates: US National Institutes of Health
Time to surgery and survival in head and neck cancer
CJ Rygalski, S Zhao, A Eskander, KY Zhan, EA Mroz, G Brock, ...
Annals of surgical oncology 28, 877-885, 2021
Mandates: US National Institutes of Health
Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial
S Kim, E Wuthrick, D Blakaj, Z Eroglu, C Verschraegen, R Thapa, M Mills, ...
The Lancet 400 (10357), 1008-1019, 2022
Mandates: US National Institutes of Health
Evolutionary and biophysical relationships among the papillomavirus E2 proteins
DM Blakaj, N Fernandez-Fuentes, Z Chen, R Hegde, A Fiser, RD Burk, ...
Frontiers in bioscience: a journal and virtual library 14, 900, 2009
Mandates: US National Institutes of Health
Emerging concepts and novel strategies in radiation therapy for laryngeal cancer management
ME Gamez, A Blakaj, W Zoller, M Bonomi, DM Blakaj
Cancers 12 (6), 1651, 2020
Mandates: US National Institutes of Health
Association of an intact E2 gene with higher HPV viral load, higher viral oncogene expression, and improved clinical outcome in HPV16 positive head and neck …
NV Anayannis, NF Schlecht, M Ben-Dayan, RV Smith, TJ Belbin, TJ Ow, ...
PloS one 13 (2), e0191581, 2018
Mandates: US National Institutes of Health, UK Medical Research Council
LCL161, a SMAC-mimetic, preferentially radiosensitizes human papillomavirus–negative head and neck squamous cell carcinoma
L Yang, B Kumar, C Shen, S Zhao, D Blakaj, T Li, M Romito, TN Teknos, ...
Molecular cancer therapeutics 18 (6), 1025-1035, 2019
Mandates: US National Institutes of Health
Sinonasal adenoid cystic carcinoma: Treatment outcomes and association with human papillomavirus
ED Miller, DM Blakaj, BJ Swanson, W Xiao, ML Gillison, L Wei, AD Bhatt, ...
Head & neck 39 (7), 1405-1411, 2017
Mandates: US National Institutes of Health
Detection of an abasic site in RNA with stem-loop DNA beacons: Application to an activity assay for Ricin Toxin A-Chain
S Roday, MB Sturm, DM Blakaj, VL Schramm
Journal of biochemical and biophysical methods 70 (6), 945-953, 2008
Mandates: US National Institutes of Health
The genomics and epigenetics of olfactory neuroblastoma: A systematic review
RP Kaur, E Izumchenko, DM Blakaj, N Mladkova, M Lechner, ...
Laryngoscope investigative otolaryngology 6 (4), 721-728, 2021
Mandates: US National Institutes of Health
Safety of nivolumab added to chemoradiation therapy platforms for intermediate and high-risk locoregionally advanced head and neck squamous cell carcinoma: RTOG Foundation 3504
ML Gillison, RL Ferris, J Harris, AD Colevas, LK Mell, C Kong, RC Jordan, ...
International Journal of Radiation Oncology* Biology* Physics 115 (4), 847-860, 2023
Mandates: US National Institutes of Health
NRG-HN003: Phase I and expansion cohort study of adjuvant pembrolizumab, cisplatin and radiation therapy in pathologically high-risk head and neck cancer
JE Bauman, J Harris, R Uppaluri, M Yao, RL Ferris, J Chen, RC Jordan, ...
Cancers 13 (12), 2882, 2021
Mandates: US National Institutes of Health
Effect of adjuvant radiotherapy treatment center volume on overall survival
R Philips, D Martin, A Eskander, J Schord, N Brown, S Zhao, G Brock, ...
Oral oncology 78, 46-51, 2018
Mandates: US National Institutes of Health
Association between tumor microbiome and hypoxia across anatomic subsites of head and neck cancers
A Dhakal, R Upadhyay, C Wheeler, R Hoyd, V Karivedu, ME Gamez, ...
International journal of molecular sciences 23 (24), 15531, 2022
Mandates: US National Institutes of Health
Sinonasal teratocarcinosarcoma: a therapeutic dilemma
GP Suarez, K Dibs, RL Carrau, L Schoenfield, DM Blakaj, G Tinoco
BMJ Case Reports CP 15 (11), e252429, 2022
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program